Key facts
- BrainPatch’s last known valuation is $7.4M (Jul 2024).
- It has raised $1.2M; the latest was Later Stage VC in Dec 2026.
- Notable investors include Innovate UK, European Union, Accelerate Cambridge, Big Sky Capital, D&FG Elements — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for BrainPatch
- ·The full record, as it builds
Funding rounds
No funding rounds for BrainPatch are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrainPatch
Developer of a computer-brain interface designed to help doctors measure brain activity. The company's platform offers an artificial intelligence package, hardware, and applications to developers, professionals, and patients to carry out brain simulations for early detection of non-invasive brain stimulation, enabling patients to recover from neurological diseases.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2018
- Employees
- 8
- Website
- brainpatch.ai/
- Ownership
- Privately Held (backing)
BrainPatch doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrainPatch shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrainPatch in its N-PORT filings yet. We sweep new filings monthly.